Stay Current With CID4

Stay up to date on the
latest news from CID4.

CID4 Twitter Feed

Quarterly Newsletters

The CID4 Report Vol. I No. I The CID4 Report Vol. I No. I (2765 KB)

View All

Blog Topics

CID4 oHours: How to Form Your Bioscience Company

(Tuesday, July 10, 2012)

CID4 is holding its Boulder edition of oHours Session #1: How to Form Your Bioscience Company on Tuesday 24 July. This month’s Session host is Richard C. Duke, Ph.D. (see bio below). 

Be certain to RSVP for CID4 oHours! 
These private one-on-one sessions are limited and will fill up fast! 

DATE: Tuesday 24 July 
TIME: 10AM – 12PM PLACE: BioFrontiers - Caruthers Brown Entrepreneurship Office 
RSVP: [HERE] i. Click RSVP link ii. Select time slot iii. Follow instructions 

oHours provides private, confidential, one-on-one meetings, hosted by domain experts who are versed in successfully starting and running life science companies.  oHours provides the Colorado life science ecosystem with an additional resource that adds to the basket of knowledge exchange opportunities available in our community via free access to subject matter experts who are available to directly answer your specific business and/or technical questions, or accelerate the elucidation of your inquiry(ies). 

HOST BIO: Dr. Richard Duke is a biotechnology executive, inventor, biomedical researcher and serial entrepreneur with nearly twenty years of experience in building, financing, and managing start-up biotechnology companies based on inventions made in Colorado’s non-profit research institutions. He is currently Founder and Chief Scientific Officer of the Colorado Institute for Drug, Device and Diagnostic Development (CID4). He has been involved in creating and managing six spin-outs from the University of Colorado School of Medicine including GlobeImmune, Newellink, Sierra Neuropharmaceuticals, ApopLogic Pharmaceuticals, PeptiVir, and Aurora Oncology. These Colorado-based companies have raised more than $150 million in financing and have multiple products in phase 1 and 2 human clinical trials. In addition to his entrepreneurial activities, Dr. Duke has over twenty years of experience in cutting-edge biomedical research and is a tenured faculty member in the Departments of Medicine (Medical Oncology) and Immunology at the University of Colorado Denver. Dr. Duke has provided independent 3rd-party research analysis in the life sciences sector to Janus Capital and to venture capital firms.
Comments

CID4 oHours: How to Form Your Bioscience Company

(Tuesday, July 03, 2012)
CID4 is holding oHours Session #1: How to Form Your Bioscience Company on Tuesday 10 July. This month’s Session host is Richard C. Duke, Ph.D. (see bio below). As with all oHours Sessions the content covered will be duplicated on dates at both Fitzsimons and Boulder campuses. 

Be certain to RSVP for CID4 oHours! 
These private one-on-one sessions are limited and will fill up fast! 

DATE: Tuesday 10 July 
TIME: 10AM – 12PM PLACE: Fitzsimons Bioscience Park, Amgen Conf. Rm. 
RSVP: [HERE] i. Click RSVP link ii. Select time slot iii. Follow instructions 

Stay tuned for RSVP details for the Tuesday 24 July Boulder Session. oHours provides private, confidential, one-on-one meetings, hosted by domain experts who are versed in successfully starting and running life science companies. 

oHours provides the Colorado life science ecosystem with an additional resource that adds to the basket of knowledge exchange opportunities available in our community via free access to subject matter experts who are available to directly answer your specific business and/or technical questions, or accelerate the elucidation of your inquiry(ies). 

HOST BIO: Dr. Richard Duke is a biotechnology executive, inventor, biomedical researcher and serial entrepreneur with nearly twenty years of experience in building, financing, and managing start-up biotechnology companies based on inventions made in Colorado’s non-profit research institutions. He is currently Founder and Chief Scientific Officer of the Colorado Institute for Drug, Device and Diagnostic Development (CID4). He has been involved in creating and managing six spin-outs from the University of Colorado School of Medicine including GlobeImmune, Newellink, Sierra Neuropharmaceuticals, ApopLogic Pharmaceuticals, PeptiVir, and Aurora Oncology. These Colorado-based companies have raised more than $150 million in financing and have multiple products in phase 1 and 2 human clinical trials. In addition to his entrepreneurial activities, Dr. Duke has over twenty years of experience in cutting-edge biomedical research and is a tenured faculty member in the Departments of Medicine (Medical Oncology) and Immunology at the University of Colorado Denver. Dr. Duke has provided independent 3rd-party research analysis in the life sciences sector to Janus Capital and to venture capital firms.
Comments

CID4 Announces the Launch of oHours!

(Wednesday, May 23, 2012)

Come learn how oHours, a new community-service offering, works and find out how oHours may benefit you and your company. Details will be shared at two introductory sessions: 


1) Monday, 4 June, 12PM @ Fitzsimons Bioscience Ctr., Amgen Conf. Rm. 
2) Thursday, 7 June 12 PM @ CU Boulder, Caruthers Biotech, B-Wing Rm. B331 

*Lunch-will-be-Served* 

Whether you are an entrepreneur, scientist, academic, clinician, industry veteran, post-doc or graduate student, the CID4 oHours platform provides a diverse array of high-quality mission critical answers that you are looking for. 

Specifically, oHours provides private, confidential, one-on-one meetings, hosted by domain experts who are versed in successfully starting and running life science companies. oHours provides the Colorado life science ecosystem with an additional resource that adds to the basket of knowledge exchange/transfer opportunities available in our community via free access to subject matter experts who are available to directly answer your specific and/or technical questions, or accelerate the elucidation of your inquiry(ies). 

The two introductory sessions will provide you with a schedule of planned program content, session schedules and, instructions on how to access and secure appointments online. In addition, attendees are provided with an opportunity to voice your detailed needs which will aid in shaping subsequent oHours Topics. 

We hope to see you at our interactive oHours introductory sessions. 

*Kindly RSVP ASAP* to arubenstein@cid4.com and indicate which session you plan to attend. 

Download the informational flyer [HERE]


Comments

Sophono Named Colorado Company to Watch Finalist

(Monday, April 09, 2012)
Congratulations to Sophono for being named a 2012 Colorado Company to Watch, Finalist, by the Colorado Office of Economic Development & International Trade. The Boulder-based, commercial-stage medical device company is focused on abutment-free bone anchored conduction hearing devices. Learn more about the great strides Sophono is making [HERE]. 

CID4 is pleased to see its partnership with Sophono progress as we continue to execute upon our mission to advance the Colorado bioscience ecosystem through company creation and job growth. The Sophono team, led by CEO Jim Kasic, is driving the economic development of Colorado while bringing to market critical advances in and new options for those suffering from hearing loss. Since CID4’s original participation, Sophono raised significant investment capital, received FDA clearance to market their Alpha1(m) device, increased full-time hires and evolved from a development-stage to commercial entity with the initiation of product sales. 

Colorado Companies to Watch energizes the state of Colorado by recognizing companies that are developing valuable products and services, creating quality jobs, enriching communities and creating new industries throughout the state. These companies fuel the economic fire of Colorado by accounting for much of the economic growth and economic independence of individuals throughout the state. In order to be eligible for nomination these companies must possess attributes such as: being privately-held, Colorado headquartered, growth focused, with 6-99 full-time equivalent employees, have sales of $750,000 to $50 million, and demonstrate the intent and capacity to grow based on evidence such as: employee or sales growth, exceptional entrepreneurial leadership, sustainable competitive advantage or other notable factor(s) that showcase the company’s success. 

This unique awards program produces a multitude of benefits for all stakeholders. Participating companies have the opportunity to gain increased visibility in local and state communities as well as to improve stakeholder relationships and contribute to a dynamic business environment. Citizens have increased access to rewarding income opportunities and are able to build pride in innovative and valuable entrepreneurial companies, and the state of Colorado is able to showcase trend-setting leaders in diverse entrepreneurial fields that strengthen the state's economy. 

You are cordially invited to attend the 4th Annual, Colorado Companies to Watch Gala Awards Dinner, Friday 22 June at the Denver Marriott City Center. Additional details and purchase tickets [HERE].
Comments

CID4 Seeks Graduate Interns for 2011/2012 Academic Calendar

(Tuesday, October 18, 2011)

UPDATE | The Application Deadline Has Been Extended to COB Monday 7 November

CID4 is now seeking graduate student interns for the remaining 2011/2012 academic calendar.

Graduate interns will have an opportunity to be involved in many aspects of business development, implementation and program activities while providing key support to management and staff. Additionally, all CID4 interns share responsibilities for administrative tasks that keep the office running smoothly and ensure top quality program support. In a busy professional setting, candidates must be good team players, know how to prioritize tasks and manage their time well. Expect to allocate a minimum of ten-hours per week to your internship.

Under the supervision of senior management, the CID4 graduate intern(s) will assist in the construction of a competitive intelligence virtual library that may ultimately function as an important shared resource for the entire Colorado bioscience ecosystem. In addition, assistance with research and due diligence, and other development projects are required.

To receive the application packet forward your resume to arubenstein@cid4.com. 

Application deadline for 2011/2012 academic calendar appointments is October 31.

Download job description here.


Comments